Search

everythinglearnresearchcommunity

for

Search:↓

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

P144® improves hypertrophic scars by reducing size and thickness and increasing elasticity.

Botulinum toxin type A injections improved hair growth and scalp health in a woman with radiation-induced hair loss.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

New drug delivery systems show promise in effectively treating pathological scars.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Hair helps prevent scalp skin cancer by supporting immune protection.

AKN is a chronic scalp condition in African-descended males, treated with topicals, antibiotics, steroids, and sometimes surgery or laser.

The right cells and signals can potentially lead to scarless wound healing, with a mix of natural and external wound healing controllers possibly being the best way to achieve this.

Wedelolactone may help treat lung fibrosis by reducing inflammation and lung damage.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Pulsed infrared laser can effectively reduce symptoms of pseudofolliculitis barbae.

People with atopic dermatitis have a higher risk of developing keloids, especially women, those under 40, and those with severe symptoms.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Certain microRNAs might help identify and understand Frontal Fibrosing Alopecia.

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

Bioengineered microneedles and nanomedicine offer promising, precise treatments for tissue regeneration.

Advancements in wound healing aim to improve personalized treatments and enhance healing outcomes.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Engineered exosomes with EGF and FGF improved hair growth in mice with hair loss.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

The combination therapy improved hair growth and thickness in people with androgenetic alopecia.

Frontal fibrosing alopecia can occur in men and may be linked to immune triggers like vaccines.

LncRNAs play a crucial role in muscle regulation and could help develop treatments for Duchenne muscular dystrophy.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.